+

WO2009086614A1 - Procédé et application d'une composition alimentaire symbiotique pour humains et animaux - Google Patents

Procédé et application d'une composition alimentaire symbiotique pour humains et animaux Download PDF

Info

Publication number
WO2009086614A1
WO2009086614A1 PCT/CA2008/000021 CA2008000021W WO2009086614A1 WO 2009086614 A1 WO2009086614 A1 WO 2009086614A1 CA 2008000021 W CA2008000021 W CA 2008000021W WO 2009086614 A1 WO2009086614 A1 WO 2009086614A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
component
food
synbiotic
feed
Prior art date
Application number
PCT/CA2008/000021
Other languages
English (en)
Inventor
Albert Knab
Antonina N. Vassilieva
Original Assignee
Albert Knab
Vassilieva Antonina N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert Knab, Vassilieva Antonina N filed Critical Albert Knab
Priority to PCT/CA2008/000021 priority Critical patent/WO2009086614A1/fr
Publication of WO2009086614A1 publication Critical patent/WO2009086614A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to the field of functional foods, nutrition, biologically active fermented functional foods with synbiotic properties, and more specifically to a method of bioactivation mucilaginous seed, synbiotic food/feed composition based on bioactivated mucilaginous seed, and use thereof.
  • synbiotic foods both prebiotic and probiotic benefits are combined in one food product. When properly prepared and consumed, they may stimulate the immune system and promote gastrointestinal and colon health, thereby enhancing quality of life and well being of humans and animals (Sharon Gerdes, 2005)
  • the present invention includes a synbiotic food/feed composition and methods of preparation and application thereof, that result in the improvement of the well being humans and animals.
  • the synbiotic food/feed composition is prepared in a process of bioactivation of mucilaginous seed to a prescribed point where a desired synbiotic food/feed composition is achieved and can be consumed fresh or dry (stabilized) or in prepared foods.
  • the present composition is based on bioactivated mucilaginous seed and contains a combination of probiotic components (with log 8-9 CFU in suggested serving), prebiotic components (with improved ratio of fibers), essential fatty acid components, vitamin components, enzyme components, mineral components, phytochemical components, and nutritional components.
  • this synbiotic food/feed composition might be enriched with nutraceutical components.
  • the present synbiotic food/feed composition is reasonable in cost, stable in ambient environment without refrigeration, and easy to consume or use as a functional food or as a functional food ingredient in consumer products.
  • the synbiotic food/feed composition is administered to human or animal.
  • the present invention results in beneficial change in well being including but not limited to, digestive and immune function, enhanced ability to cope with the physical demands of emotional and /or physical stress, energy level, bowel regularity; facilitating healthy weight loss; a reduction in the levels of toxins in a gastrointestinal tract, a lessening of arthritic symptoms linked discomfort, an improvement of skin and hair condition, a regulation of blood glucose levels, an improvement in the levels of LDL and HDL cholesterol, a lessening of "dry eye” syndrome, or combination thereof in a said human or animal.
  • the present invention contributes to both male and female health, and to the offspring of human and animals born from those consuming a synbiotic food/feed composition.
  • probiotics refers to live organisms which when administered in adequate amounts confer a health benefit on the host
  • prebiotics refers to substances that stimulate the growth and activity of beneficial bacteria (probiotics) of the intestinal flora
  • FIG. 1 shows a process flow diagram illustrating a method of preparing synbiotic food/feed composition, based on bioactivated mucilaginous seeds
  • FIG. 2 shows a process of enrichment and stabilizing probiotic in synbiotic composition based on mucilaginous seeds
  • FIG. 3 illustrates properties of flaxseed based synbiotic food/feed composition
  • Present method of preparation synbiotic food/feed composition is based on processing of mucilaginous seed including bioactivation (sequential fermentation, sprouting, malting) accompanied by drying.
  • Step 1 Fermentation.
  • the ideal protocol for adding moisture to mucilaginous seeds is at a prescribed ratio of water volume to seed. Water is added in specific volume and over a period of time, with agitation based on skills those experienced in the art. Specifically designed machinery may also be used, until a desired level of fermentation is reached.
  • Step 2 Germination/Sprouting.
  • Traditional methodologies of sprouting would suggest the soaking of the seed for a period of approximately 6 hours in water at approximately 68.degrees F. Due to the nature of mucilaginous seeds, this cannot be done without damaging of their unique properties. Adding equal quantities of water to mucilaginous oil seeds produces a porridge-like mixture and may cause the seed to die.
  • the ideal protocol for adding moisture to mucilaginous oil seeds is at a prescribed ratio of water volume to seed. Water is added in specific volume and over a period of time, with agitation based on skills those experienced in the art. Specifically designed machinery may also be used, until a desired level of germination/sprouting is reached.
  • Step 3 Malting. By manipulation of the oxygen supply and temperature, those experienced in the art are able to regulate level of probiotic bacteria and prebiotics in malting seed.
  • Step 4 Drying is applied to bioactivated.mucilaginous seeds during further processing. Low temperatures are combined with regulated airflow in specifically designed machinery to cause rapid dehydration and stabilization of synbiotic food/feed composition. [0031] Grinding, milling, powdering or micro-cutting can be additional steps of processing, customized synbiotic food/feed compositions for further consumption.
  • a protective shield or coat for biogenic components of the bioactivated mucilaginous seeds is created during processing.
  • the novel process causes a Bio-encapsulation of the biogenic components in a cell-friendly coating.
  • the resulting bio-encapsulated benficial bacteria, enzymes, vitamins, essential fatty acids, colloidal minerals, nutrients and nutraceuticals are delivered and digested in a more bio-available fashion during passage through the digestive system of human or animals.
  • a synbiotic food/feed composition comprises the following constituents: probiotic component, prebiotic component, essential fatty acid component, vitamin component, enzyme component, mineral component, phytochemical component, nutraceutical component, nutritional component, and/or a combination thereof.
  • Probiotic component in synbiotic food/feed composition is selected from the probiotic cultures consisting of soil-based microorganisms accompanied by Lactobacillus, Bifidobacterium, Saccharomyces, other probiotic cultures, and/or combination thereof, with log CFU no less than 7 per gram of synbiotic food/feed composition, or more than 8 in suggested serving.
  • Probiotic component is stabilized, immobilized and bio-encapsulated
  • a prebiotic component is selected from a fiber of plant origin, with improved formula/ratio of soluble/non-soluble fibers
  • Essential fatty acids component is selected from the group consisting of Omega-3 polyunsaturated fatty acid, Omega-6 polyunsaturated fatty acid, Omega-9 polyunsaturated fatty acid, and/or a combination thereof, and is present in bio-encapsulated form preventing essential fatty acids from rapid oxidation.
  • a vitamin component in synbiotic food/feed composition comprises of at least one vitamin selected from a group consisting of vitamin A, B, C, D, E, folic acid, choline, pantothenic acid, niacin, and/or combination thereof. Vitamin component is further characterized as bio-encapsulated
  • Enzyme component of synbiotic food/feed composition comprises at least one enzyme selected from a group consisting of lipase, protease, cellulase, amylase, and other active enzymes, and/or a combination thereof, where enzyme component is further characterized as bio-encapsulated
  • Mineral component of synbiotic food/feed composition comprises at least one mineral selected from a group consisting of an iron, calcium, copper, chromium, boron, magnesium, iodine, potassium, sodium, zinc, and/or combination thereof, in colloidal and bio-encapsulated form.
  • a phytochemical component in synbiotic food/feed composition is selected from a group which includes lignans, sulphoraphane, other phytochemicals, and/or a combination thereof, in bio-encapsulated form.
  • a nutraceutical component of synbiotic food/feed composition comprises at least one nutraceutical selected from a group, which includes stevia, other nutraceuticals, and/or a combination thereof, and is bio-encapsulated.
  • Nutritional component of synbiotic food/feed composition is at least one component is selected from vegetable protein, carbohydrates, lipids, or combination thereof, in bio- encapsulated form.
  • the synbiotic food/feed composition is stable for at least one year when stored at ambient temperature and ambient humidity level.
  • the synbiotic food/feed composition might be in a form of seed, ground/milled/micro-cut dosage, tablet or capsule.
  • the synbiotic food/feed composition may be consumed by human as a food product, or included as a functional ingredient in consumer products which may include but are not limited to dry soup mix, dry sauce mix, dry energy drink mix, dry baby food mix, cereals, porridge, pastas, chips, crackers, dry breads, dry cake mix, dry pudding mix, yogurts, frozen yogurts, frozen meat and fish products, frozen meat replacement products, ice creams, frozen pizzas, breads, cookies, energy bars, cheeses, spreads, butters, peanut butters, chocolates, nanofoods [0045]
  • the synbiotic food/feed composition when consumed by animals (bovine, caprine, porcine, equine, fish, and birds), can be used as a single feed product, a functional feed ingredient, in the form of but not limited to powder, treats or cookies, pellets, chewable snacks, and feed through for meat and dairy products from animals, consuming the synbiotic food/feed composition.
  • the application of the synbiotic food/feed composition results in a beneficial change in the well being including but not limited to, digestive and immune function, enhanced ability to cope with the physical demands of emotional and /or physical stress, energy level, bowel regularity; facilitating healthy weight loss; a reduction in the levels of toxins in a gastrointestinal tract, a lessening of arthritic symptoms linked discomfort, an improvement of skin and hair condition, a regulation of blood glucose levels, an improvement in the levels of LDL and HDL cholesterol, a lessening of "dry eye” syndrome, or combination thereof in a said human or animal. It contributes to both male and female health, and to the next generation of human and animals born from those consuming a synbiotic food/feed composition.
  • Flaxseed based synbiotic composition comprising the following constituents: probiotic component, prebiotic component, essential fatty acid component, vitamin component, enzyme component, mineral component, phytochemical component, and nutritional component, in patients of 4 doctors at the University of Alabama Genesis Park laboratory. Each doctor was assigned five patients with various medical conditions. Flaxseed based synbiotic composition has been consumed twice a day, in amount of 1Og, with additional water intake, for a period of 6-7 months. The following results are what was reported using venous blood chemistries and a medical, sociological and psychological inventory of the patent's life history. This was a very unusual clinical study due to the fact that there are so many variables and factors to check medically, socially and psychologically.
  • Her mother first reported that her daughter has adolescent rheumatoid arthritis with chronic bone disease and requires two canes to walk and maintain her balance, significant vision problems and severe acid reflux. After taking flaxseed based synbiotic composition, her mother reports that her daughter has no problems with acid reflux and her gait is now considerably improved. Her Rh-factor and qualitative venous blood profiles have improved 42%. Her immune system is much stronger and her vision problems are vastly improved.
  • the patients dairy contains comments regarding normalizing of bowel movement and elimination of her abdomen pain in 2 weeks after beginning of administration of flaxseed synbiotic composition. She also experienced relief of both menstrual pain and symptoms of cold happened during the trial.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne une composition alimentaire symbiotique qui comprend un constituant de graines mucilagineuses. La composition réunit des caractéristiques nutritionnelles, chimiques et biologiques supérieures, lesquelles, seules et en association, agissent pour améliorer le bien-être des humains et des animaux. L'invention concerne également les procédés de préparation et d'application de la composition alimentaire symbiotique pour des humains et des animaux.
PCT/CA2008/000021 2008-01-08 2008-01-08 Procédé et application d'une composition alimentaire symbiotique pour humains et animaux WO2009086614A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CA2008/000021 WO2009086614A1 (fr) 2008-01-08 2008-01-08 Procédé et application d'une composition alimentaire symbiotique pour humains et animaux

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA2008/000021 WO2009086614A1 (fr) 2008-01-08 2008-01-08 Procédé et application d'une composition alimentaire symbiotique pour humains et animaux

Publications (1)

Publication Number Publication Date
WO2009086614A1 true WO2009086614A1 (fr) 2009-07-16

Family

ID=40852720

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2008/000021 WO2009086614A1 (fr) 2008-01-08 2008-01-08 Procédé et application d'une composition alimentaire symbiotique pour humains et animaux

Country Status (1)

Country Link
WO (1) WO2009086614A1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009105048A3 (fr) * 2008-02-19 2009-11-19 Rached Smida Nouvelles applications du hdl reconstitué
EP2517699A1 (fr) * 2011-04-29 2012-10-31 Biotechnobel SA Composition pour la prévention et le traitement de l'arthrite
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
JP2021020855A (ja) * 2019-07-24 2021-02-18 国立大学法人 東京大学 血中尿酸値低下剤及び血中尿酸値低下用食品組成物
WO2021205242A1 (fr) * 2020-04-09 2021-10-14 Pandurangan Prabhakaran Composition thérapeutique
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281463A1 (fr) * 1999-08-26 2001-02-26 Stanley H. Zlotkin Composition comprenant une combinaison de micronutriments et de composes prebiotiques, probiotiques et symbiotiques
CA2395253A1 (fr) * 1999-12-15 2001-07-05 Cargill Incorporated Procede de maltage de grains
CA2452997A1 (fr) * 2001-07-06 2003-01-16 Canadian Organic Sprout Company Jeunes pousses de lin et procede de germination
CA2604838A1 (fr) * 2005-04-11 2006-10-19 The Iams Company Compositions alimentaires pour animal domestique comprenant deux composants
CA2615694A1 (fr) * 2005-07-27 2007-02-01 Psimedica Ltd Aliment contenant du silicium
WO2007107638A1 (fr) * 2006-03-20 2007-09-27 Elixi Oil Oy Produit alimentaire fermenté
WO2007150047A1 (fr) * 2006-06-22 2007-12-27 Martek Biosciences Corporation Compositions de composé labile encapsulées et leurs procédés de fabrication

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281463A1 (fr) * 1999-08-26 2001-02-26 Stanley H. Zlotkin Composition comprenant une combinaison de micronutriments et de composes prebiotiques, probiotiques et symbiotiques
CA2395253A1 (fr) * 1999-12-15 2001-07-05 Cargill Incorporated Procede de maltage de grains
CA2452997A1 (fr) * 2001-07-06 2003-01-16 Canadian Organic Sprout Company Jeunes pousses de lin et procede de germination
CA2604838A1 (fr) * 2005-04-11 2006-10-19 The Iams Company Compositions alimentaires pour animal domestique comprenant deux composants
CA2615694A1 (fr) * 2005-07-27 2007-02-01 Psimedica Ltd Aliment contenant du silicium
WO2007107638A1 (fr) * 2006-03-20 2007-09-27 Elixi Oil Oy Produit alimentaire fermenté
WO2007150047A1 (fr) * 2006-06-22 2007-12-27 Martek Biosciences Corporation Compositions de composé labile encapsulées et leurs procédés de fabrication

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009105048A3 (fr) * 2008-02-19 2009-11-19 Rached Smida Nouvelles applications du hdl reconstitué
EP2517699A1 (fr) * 2011-04-29 2012-10-31 Biotechnobel SA Composition pour la prévention et le traitement de l'arthrite
WO2012146773A1 (fr) * 2011-04-29 2012-11-01 Biotechnobel S.A. Composition pour la prévention et le traitement de la polyarthrite rhumatoïde
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US11633451B2 (en) 2016-03-31 2023-04-25 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US11998575B2 (en) 2016-03-31 2024-06-04 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
JP2021020855A (ja) * 2019-07-24 2021-02-18 国立大学法人 東京大学 血中尿酸値低下剤及び血中尿酸値低下用食品組成物
JP7500037B2 (ja) 2019-07-24 2024-06-17 国立大学法人 東京大学 血中尿酸値低下剤及び血中尿酸値低下用食品組成物
WO2021205242A1 (fr) * 2020-04-09 2021-10-14 Pandurangan Prabhakaran Composition thérapeutique

Similar Documents

Publication Publication Date Title
CN103282013B (zh) 适合用于促进健康的皮肤的方法和组合物
CN108244252A (zh) 益生菌多元蛋白粉及其制备方法
CN110338402A (zh) 一种复合益生菌粉及其制备方法
WO2009086614A1 (fr) Procédé et application d'une composition alimentaire symbiotique pour humains et animaux
CN105230987A (zh) 一种宠物幼犬用保健剂
CN109640688A (zh) 用于调节犬科动物的胃肠微生物区系的组合物和方法
JP2007054041A (ja) 養鶏飼料並びに卵
CN107568736A (zh) 解酒醒酒医学配方食品
CN109673861A (zh) 一种猫用藻菌类营养化毛膏及其制备方法
KR20110007463A (ko) 쌀눈과 미강과 밀기울이 함유된 발효식품 및 그 제조방법
CN106578571A (zh) 改善宠物肠道功能的营养组合物、营养制剂及其制备方法和应用
CN108450938A (zh) 一种减脂代餐粉及其制备方法
JP2013014617A (ja) 中鎖トリグリセリド油と組み合わせた３−ｈｐａ産生性ラクトバチルス菌株を使用して哺乳動物の免疫機能を向上させる方法
CN108243603A (zh) 使用长双歧杆菌调节情绪反应性并治疗或预防亚临床心境紊乱的方法和组合物
JP2012509669A (ja) 食物摂取量を変化させ、栄養素消化率を改変し、糞便の質および／または排便回数を変化させるための方法
CN107691785A (zh) 一种含植物提取物的饲料添加剂及其制备方法与应用
CN107223792A (zh) 肉鸡饲料添加剂及其制备方法和应用
CN110771748A (zh) 一种益智健骨延缓老年犬衰老的营养强化复合剂及其制备方法
KR20100037312A (ko) 유산균을 이용한 분말형 건강보조식품의 제조방법
CN108720024A (zh) 一种活性多酶维生素细胞营养液
KR20100037309A (ko) 유산균을 이용한 환형 건강보조식품의 제조방법
Totawar Critical review of the utilization of Panchagavya in the form of Nutraceuticals
Novhorodska Sour milk drink with prebiotic properties
KR20200118320A (ko) 산란계용 사료의 제조방법
Aluko Probiotic Viability and Storage Stability of Yoghurt Enriched with Baobab Pulp (Adansonia digitata)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08700492

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08700492

Country of ref document: EP

Kind code of ref document: A1

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载